Cite
HARVARD Citation
Bas, O. et al. (2020). Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma. Journal of oncology pharmacy practice. pp. 1230-1233. [Online].